The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

we have decided to discontinue our insulin patch pump program and initiate an organizational restructuring plan. We believe this approach will streamline operations, reduce costs and enhance our ...

which was first announced in May 2023 before being abandoned a few months later after a federal judge blocked EOFlow from selling its insulin patch pump in the US. Medtronic said its decision to ...

Insulin pumps are a medical device used by people with ... but more recent models have taken the form of a patch with a pump mounted directly upon it. When [Pete Schwamb]’s daughter received ...

Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to ...

Modern insulin pumps are self-contained devices that attach to a user’s skin via an adhesive patch, and are responsible for administering insulin as needed. Curious as to what was inside ...

Medtech giant Medtronic has decided not to go ahead with a planned acquisition of EOFlow, a developer of patch-based insulin pumps, saying that there have been “multiple breaches” of their ...

The diabetes device company said the layoffs were the result of a recent decision to discontinue its insulin patch pump program and an organizational restructuring. A medical device company plans ...

The Irvine, California-based company makes an insulin pump called the iLet Bionic Pancreas, which was cleared by the Food and ...

CHICAGO, NY, UNITED STATES, January 17, 2025 /EINPresswire / -- The global insulin pump <a target=_blank href= ...

The company filed a lawsuit against EOFlow in August 2023, claiming that EOFlow copied the design for its insulin patch pump that delivers the therapy to people with diabetes. EOFlow hired several ...